UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin

Human molecular genetics, 2008-01, Vol.17 (2), p.170-178

2008

Volltextzugriff (PDF)

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

Nature genetics, 2004-06, Vol.36 (6), p.585-595

2004

Volltextzugriff (PDF)

Transcriptional abnormalities in Huntington disease

Trends in genetics, 2003-05, Vol.19 (5), p.233-238

2003

Volltextzugriff (PDF)

Laforin, the most common protein mutated in Lafora disease, regulates autophagy

Human molecular genetics, 2010-07, Vol.19 (14), p.2867-2876

2010

Volltextzugriff (PDF)

Autophagic activity in neuronal cell death

Neuroscience bulletin, 2015-08, Vol.31 (4), p.382-394

2015

Volltextzugriff (PDF)

Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease

Human molecular genetics, 2005-11, Vol.14 (22), p.3425-3433

2005

Volltextzugriff (PDF)

A Kinesin Heavy Chain ( KIF5A) Mutation in Hereditary Spastic Paraplegia (SPG10)

American journal of human genetics, 2002-11, Vol.71 (5), p.1189-1194

2002

Volltextzugriff (PDF)

Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles

Brain (London, England : 1878), 2006-04, Vol.129 (4), p.877-886

2006

Volltextzugriff (PDF)

Can autophagy protect against neurodegeneration caused by aggregate-prone proteins?

Neuroreport, 2004-11, Vol.15 (16), p.2443-2445

2004

Volltextzugriff (PDF)

Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation

Human molecular genetics, 2008-04, Vol.17 (8), p.1097-1108

2008

Volltextzugriff (PDF)

Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy

Human molecular genetics, 2002-05, Vol.11 (9), p.1107-1117

2002

Volltextzugriff (PDF)

Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease

Human molecular genetics, 2010-06, Vol.19 (11), p.2144-2153

2010

Volltextzugriff (PDF)

Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington’s disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol

BMJ open, 2024-08, Vol.14 (8), p.e087983

2024

Volltextzugriff (PDF)

Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy

Human molecular genetics, 2006-01, Vol.15 (1), p.23-31

2006

Volltextzugriff (PDF)

Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin

Human molecular genetics, 2002-05, Vol.11 (9), p.1137-1151

2002

Volltextzugriff (PDF)

An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease

Journal of neurology, 2017-12, Vol.264 (12), p.2457-2463

2017

Volltextzugriff (PDF)

Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy

Human molecular genetics, 2011-03, Vol.20 (6), p.1154-1163

2011

Volltextzugriff (PDF)

α-Synuclein levels modulate Huntington's disease in mice

Human molecular genetics, 2012-02, Vol.21 (3), p.485-494

2012

Volltextzugriff (PDF)

Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia

Neurobiology of aging, 2012-04, Vol.33 (4), p.791-803

2012

Volltextzugriff (PDF)

Four Components Describe Behavioral Symptoms in 1,120 Individuals with Late-Onset Alzheimer's Disease

Journal of the American Geriatrics Society (JAGS), 2006-09, Vol.54 (9), p.1348-1354

2006

Volltextzugriff (PDF)

Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres

Human molecular genetics, 2010-06, Vol.19 (11), p.2191-2207

2010

Volltextzugriff (PDF)

A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism

PloS one, 2008-06, Vol.3 (6), p.e2334-e2334

2008

Volltextzugriff (PDF)

Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course

Brain (London, England : 1878), 2003-04, Vol.126 (4), p.946-955

2003

Volltextzugriff (PDF)

DAPK1 variants are associated with Alzheimer's disease and allele-specific expression

Human molecular genetics, 2006-09, Vol.15 (17), p.2560-2568

2006

Volltextzugriff (PDF)

Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism

PloS one, 2012-02, Vol.7 (2), p.e31024

2012

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

ThemaNeurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(80)

Sprache

Englisch
(80)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(62)
Biological And Medical Sciences
(61)
Humans
(61)
Medical Sciences
(61)
Genetics & Heredity
(38)
Female
(32)
Male
(32)
Animals
(29)
Aged
(26)
Alzheimer Disease - Genetics
(26)
Alzheimer's Disease
(25)
Neurosciences
(24)
Fundamental And Applied Biological Sciences. Psychology
(22)
Neurosciences & Neurology
(22)
Biochemistry & Molecular Biology
(18)
Huntington Disease - Genetics
(15)
Genetics Of Eukaryotes. Biological And Molecular Evolution
(14)
Mice
(14)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

Transcriptional abnormalities in Huntington disease

Laforin, the most common protein mutated in Lafora disease, regulates autophagy

Autophagic activity in neuronal cell death

Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease

A Kinesin Heavy Chain ( KIF5A) Mutation in Hereditary Spastic Paraplegia (SPG10)

Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles

Can autophagy protect against neurodegeneration caused by aggregate-prone proteins?

Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation

Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy

Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease

Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington’s disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol

Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy

Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin

An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease

Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy

α-Synuclein levels modulate Huntington's disease in mice

Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia

Four Components Describe Behavioral Symptoms in 1,120 Individuals with Late-Onset Alzheimer's Disease

Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres

A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism

Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course

DAPK1 variants are associated with Alzheimer's disease and allele-specific expression

Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism

Aktive Filter

Suchergebnisse filtern